$96.23+1.61 (+1.70%)
Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty-controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and the Asia-Pacific.
Allient Inc. in the Technology sector is trading at $96.23 with a market capitalization of $1.6B. Wall Street consensus targets $118.00 (5 analysts), implying a +22.6% move over the next 12 months. The stock is currently 19% below its 52-week high of $118.67, remaining 30.8% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $153.77Mβ | $138.91Mβ | $143.35Mβ | $138.74Mβ | $139.58M |
| Gross Profit | $53.59Mβ | $45.38Mβ | $46.42Mβ | $46.18Mβ | $46.36M |
| Operating Income | $16.25Mβ | $10.18Mβ | $11.89Mβ | $13.03Mβ | $12.82M |
| Net Income | $10.39Mβ | $5.36Mβ | $6.38Mβ | $6.48Mβ | $5.62M |
Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty-controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and the Asia-Pacific. The comp...

Allient (ALNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ALNT, and CRCT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 3, 2026.

CRCT, PBI, ALNT, ZBRA and MNTK have been added to the Zacks Rank #1 (Strong Buy) List on September 3, 2026.

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the electronic components stocks, including Allient (NASDAQ:ALNT) and its peers.

The mean of analysts' price targets for Allient (ALNT) points to a 25.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.